article thumbnail

Formycon/Fresenius Kabi and Samsung Bioepis Settlements with J&J and Janssen Biotech regarding Ustekinumab

LexBlog IP

On August 7, 2023, Formycon AG and Fresenius Kabi announced that they have reached a settlement with Johnson & Johnson (“J&J”) in the United States relating to FYB202, a proposed ustekinumab biosimilar to STELARA®, marketed by J&J. Economic terms of the settlement were not disclosed in the press release.

article thumbnail

Celltrion Stelara (Ustekinumab) Settlement With J&J

LexBlog IP

It has been reported that Celltrion has finalized a settlement with Johnson & Johnson (“J&J”) in the United States relating to CT-P43, Celltrion’s ustekinumab biosimilar to J&J’s STELARA®, which would permit Celltrion to launch the product in the U.S. market on March 7, 2025, if approved by FDA.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

NPE Showcase – Sockeye Licensing

LexBlog IP

This installment will focus on a company named Sockeye Licensing TX, LLC. Settlement agreements are typically confidential so the exact arrangement is unclear. But what we do know is Sockeye cannot sue a defendant for activity that is already licensed. So what happened?

article thumbnail

Fish & Richardson Obtains Settlement and License Agreement for Skull Shaver in Patent Infringement Dispute with Magicfly

Fish & Richardson Trademark & Copyright Thoughts

Fish & Richardson obtained a settlement and license agreement for Skull Shaver, LLC, the market leader in uniquely designed and patented handheld electric shavers and personal grooming products, in a patent infringement lawsuit against Magicfly LLC.

article thumbnail

3 Count: Truth Settles

Plagiarism Today

First off today, Chris Cooke at Complete Music Update reports that Lizzo has reached a settlement with her former collaborators over her hit song Truth Hurts. However, now the sides have reached a confidential settlement that brings the case to an end. Let me know via Twitter @plagiarismtoday.

article thumbnail

Daniel Alexander KC says "no" on indemnity costs, blanket confidentiality orders and permission to appeal in Oxford University Innovation dispute

The IPKat

In the consequentials hearing judgment [2023] EWHC 138 , the Judge dealt with (1) royalty payments; (2) costs; (3) confidentiality; and (4) permission to appeal. Of the most interesting to this Kat was the treatment of costs (well, some of them), confidentiality and permission to appeal.

article thumbnail

3 Count: Free Cuthbert

Plagiarism Today

Finally today, Amar Mehta at Sky News reports that UK retailer Marks & Spencer has reached a settlement with German competitor Aldi over similar caterpillar cakes that both stores sold. However, now it is being reported that the two sides have reached a confidential settlement in the matter. However, the U.S.